Vanderbilt/Leipzig Partnership: Peptide Therapeutics Short Course
Learn more about: VU/LU Short Course in Peptide Therapeutics Available – Vanderbilt / Leipzig University (uni-leipzig.de)
Through the Meiler lab partnership with the Max Kade Foundation, Jens has organized a short course titled “Current Developments in Experimental and Computational Engineering of Peptide Therapeutics.” It will be taught in person from February 27th through March 3rd at the times noted in the attachment. Faculty from Leipzig and Vanderbilt Universities will teach the course in lecture and computational laboratory settings. This is non-credit, and enrollment is completed by emailing Carie Fortenberry at carie.a.fortenberry@vanderbilt.edu. Enrollment is limited due to lab space, and it is first come, first served.
Course Description:
Peptides as therapeutics are an emerging class of therapeutics modalities, due to their high binding affinities and specificities. Here we will discuss their characteristics as a therapeutic class and give an overview on recent and future developments. Furthermore, we highlight strategies for identification and optimization of peptide therapeutics. We will also cover emerging technologies for structure-based computational design of peptides using Rosetta. Specifically, we will train students in the theoretical background of computational techniques for Peptide design and provide hands-on training with respect to engineering peptides consisting of genetically encoded but also non-canonical amino acids.